AI Dermatology Platform of Cureskin Raises $20 Mn for Expansion

Cureskin is a skincare brand that offers a personalized skincare routine based on an individual’s skin type, concerns, and goals. Their products are formulated with active ingredients that are designed to target specific skin issues such as acne, hyperpigmentation, and premature aging. They offer a range of products including cleansers, toners, moisturizers, and treatments, as well as a subscription service that delivers a monthly skincare box to their customers. Cureskin is dermatologist-tested and cruelty-free, and they offer a 60-day risk-free trial for new customers.

Related: D2C Skincare Brand Foxtale Raises $14 Million, Aims for Rapid Growth

Cureskin, a dermatology platform powered by AI, has secured $20 million in its Series B funding round, spearheaded by the venture capital firm HealthQuad. Alongside, notable investors like JSW Ventures, Khosla Ventures, and Sharrp Ventures also contributed to the round.

Expressing their excitement, Cureskin mentioned that the funds will fuel their journey towards improving their services, broadening their offerings, ramping up operations, and propelling overall growth.

CureSkin established in 2017 by Guna Kakulapati, Ramakrishna Rajanna, and Charu Sharma, utilizes advanced AI technology within its app to deliver personalized skin and hair care solutions, as prescribed by dermatologists. Moreover, the platform provides guidance and follow-ups with dermatologists for its users.

“This funding will not only boost our AI capabilities but also fuel our growth and broaden our range of solutions. Our goal is to ensure millions of people nationwide achieve optimal skin and hair health,” remarked Kakulapati, co-founder, and CEO of CureSkin, regarding the recent funding round.

In its most recent funding round, the Bengaluru-based startup has amassed a grand total of over $26 million in funding to date. Its last injection of funds amounted to $5 million back in 2022.

This innovative startup utilizes the power of AI to meticulously analyze over 10 million skin pixels from photographs, extracting more than 2,000 facial attributes to identify various skin conditions. Drawing from a vast database comprising over 50 million images, the platform categorizes consumers into more than 65,000 distinct profiles, offering personalized solutions tailored to their needs.

With a proud track record, the company has served upwards of 1.5 million customers, with a remarkable 80% hailing from Tier-II and III regions.

In the current scenario of a challenging funding landscape for Indian startups, there’s a glimmer of hope shining on the healthtech front. Despite the overall decline in funding, healthtech startups have been catching the eye of investors lately.

CureSkin, an AI-powered dermatology platform, recently secured $20 million in Series B funding, led by HealthQuad and joined by notable investors JSW Ventures, Khosla Ventures, and Sharrp Ventures. The funding aims to improve services, expand offerings, and accelerate overall growth. Leveraging advanced AI technology, CureSkin meticulously analyzes skin pixels to identify various skin conditions and has served over 1.5 million customers, with 80% from Tier-II and III regions. This successful funding in a challenging landscape underscores growing investor interest in healthtech startups, offering potential for substantial advancements in the sector.